Active Awards Portfolio Dashboard
It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards
Disease | Cell Type | Therapeutic or Technology |
Institution![]() |
Stage | Project Objective | Details |
---|---|---|---|---|---|---|
IPEX Syndrome, Immune Disease |
Vital Research Opportunity | Gene Therapy, cell free | Stanford |
![]() |
IND | |
Skeletal/Smooth Muscle disorders | Adult Stem Cell | Small molecule therapy | Stanford |
![]() |
Proof of Concept | |
Kidney Failure | Adult Stem Cell | Donor cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Thymic Disorder, 22q11 Deletion/DiGeorge |
Embryonic Stem Cell, iPS Cell |
Donor cell therapy | Stanford |
![]() |
Development Candidate, Proof of Concept | |
Kidney Failure | Adult Stem Cell | Donor cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
COVID-19 | Adult Stem Cell | Small molecule therapy | Stanford |
![]() |
Development Candidate, Proof of Concept | |
COVID-19 | Adult Stem Cell | Vaccine | Stanford |
![]() |
Development Candidate, Proof of Concept | |
Stroke | Embryonic Stem Cell | Donor cell therapy | Stanford |
![]() |
IND | |
B cell cancers, Leukemia |
Adult Stem Cell | Gene-modified, personalized cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Bladder or Urinary Tract Disorder, Solid Tumors |
Embryonic Stem Cell | Donor cell therapy | Stanford |
![]() |
Development Candidate, Proof of Concept | |
Embryonic Stem Cell | Cell processing & handling | Stanford |
![]() |
Research Insights | ||
Bladder or Urinary Tract Disorder, Incontinence |
iPS Cell | Personalized cell therapy | Stanford |
![]() |
Pre-IND/IDE or Equivalent | |
Hearing Loss | Adult Stem Cell | Protein/peptide therapy | Stanford |
![]() |
Development Candidate, Proof of Concept | |
COVID-19 | iPS Cell | Model system development | UC Berkeley |
![]() |
Proof of Concept | |
Spina Bifida | Adult Stem Cell | Donor cell therapy | UC Davis |
![]() |
IND | |
Spina Bifida | Adult Stem Cell | Donor cell therapy | UC Davis |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Osteonecrosis | Adult Stem Cell | Small molecule therapy | UC Davis |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
HIV-related Lymphoma, HIV/AIDS |
Adult Stem Cell | Gene-modified, personalized cell therapy | UC Davis |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Traumatic Brain Injury | Embryonic Stem Cell | Exosomes based therapy | UC Irvine |
![]() |
Development Candidate, Proof of Concept, Research Insights | |
Huntington's Disease | Embryonic Stem Cell | Donor cell therapy | UC Irvine |
![]() |
IND | |
Neurological Disorders | Embryonic Stem Cell | Donor cell therapy | UC Irvine |
![]() |
Development Candidate, Proof of Concept | |
Traumatic Brain Injury | iPS Cell | Donor cell therapy | UC Irvine |
![]() |
Development Candidate, Research Insights | |
Retinitis Pigmentosa | Embryonic Stem Cell | Donor cell therapy | UC Irvine |
![]() |
Pre-IND/IDE or Equivalent | |
Traumatic Brain Injury | Embryonic Stem Cell | Donor cell therapy | UC Irvine |
![]() |
Pre-IND/IDE or Equivalent | |
Corneal Damage | Adult Stem Cell | Personalized cell therapy | UCLA |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Blood Disorders, Immune Disease |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Proof of Concept | |
Cancer | Adult Stem Cell | Gene-modified, donor cell therapy | UCLA |
![]() |
Development Candidate, Proof of Concept | |
Hyper IgM Syndrome, Immune Disease |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Sarcoma | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Blood Disorders | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Development Candidate, Proof of Concept | |
Multiple Myeloma | Adult Stem Cell | Personalized cell therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Sickle Cell Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
COVID-19 | Adult Stem Cell | Vaccine | UCLA |
![]() |
Development Candidate, Proof of Concept | |
COVID-19 | Adult Stem Cell | Small molecule therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Lung Cancer | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
COVID-19, Respiratory Disorders |
iPS Cell | Small molecule therapy | UCLA |
![]() |
Development Candidate, Proof of Concept | |
Immune Disease, X-linked Chronic Granulomatous Disease |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Stroke | iPS Cell | Donor cell therapy | UCLA |
![]() |
Development Candidate, Proof of Concept | |
COVID-19, Respiratory Disorders |
Adult Stem Cell | Model system development | UCLA |
![]() |
Development Candidate, Proof of Concept, Tool/Resources/Bottleneck | |
COVID-19 | Adult Stem Cell | Gene-modified, donor cell therapy | UCLA |
![]() |
Development Candidate, Proof of Concept | |
Age-related macular degeneration | iPS Cell | Personalized cell therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Leukemia, Acute Myeloid (AML), Multiple Myeloma |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Leukemia, Acute Myeloid (AML) | Cancer Stem Cell | Small molecule therapy | UCSD |
![]() |
Pre-IND/IDE or Equivalent | |
Spinal Cord Injury | Embryonic Stem Cell | Therapeutic Approach | UCSD |
![]() |
Development Candidate, Research Insights | |
Leukemia, Acute Myeloid (AML) | Embryonic Stem Cell | Donor cell therapy | UCSD |
![]() |
Pre-IND/IDE or Equivalent | |
Vascular Disease | Adult Stem Cell | Biologic | UCSD |
![]() |
Pre-IND/IDE or Equivalent | |
Heart Disease, Danon Disease |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCSD |
![]() |
Development Candidate, Proof of Concept | |
Ovarian Cancer | iPS Cell | Gene-modified, donor cell therapy | UCSD |
![]() |
Development Candidate, Proof of Concept | |
Vision Loss | iPS Cell | Small molecule therapy | UCSD |
![]() |
Development Candidate, Proof of Concept | |
Amyotrophic Lateral Sclerosis, Spinal Cord Injury |
Embryonic Stem Cell, iPS Cell |
Cell imaging & tracking | UCSD |
![]() |
Research Insights |